THALAMAG Sérénité Jour et Nuit
Food supplement declared in France, declaration No 2021-9-18
THALAMAG Sérénité Jour et Nuit, from BIOCODEX, is a food supplement declared in France. Status: withdrawn from the market on 28 November 2024. Main ingredients: Valeriana officinalis 120 mg per day, Paullinia cupana 75 mg per day, Magnesium, Vitamin C. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- THALAMAG
- Food business operator placing the product on the market
- BIOCODEX
- Status
- Withdrawn from the market on 28 November 2024
- Form
- Tablet
- Daily dose
- 1 comprimé jour et 1 comprimé nuit.
- Directions for use
- 1 comprimé jaune (jour) le matin et 1 comprimé bleu (nuit) le soir à avaler avec un verre d’eau.
- Intended populations
- Adolescents aged 11 to 17, People over 60, Men, Women
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Infants (under 1 year)
- Objectives stated by the manufacturer (these are not authorised claims)
- Sleep, Nervous system
Declaration 284703, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Valeriana officinalis L. | Racine | Autre extrait sec | 120 mg |
| Paullinia cupana Kunth | Graine | Autre extrait sec | 75 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| magnesium hydroxide | Magnesium | 250 mg | 300 mg |
| L-ascorbic acid | Vitamin C | no limit (insufficient data) | 180 mg |
Additives
E460, E341, E1201, E470b, E551, E464, E570, E422, E330, E414
Other ingredients
Spirulina major Kützing ex Gomont, Concentré de carthame, maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. Ne se substitue pas à une alimentation variée, équilibrée et à un mode de vie sain. Na pas consommer en cas de sensibilité connue à l'un des constituants. Contient de la caféine (13 mg), déconseillé aux enfants et aux femmes enceintes. Peut entrainer des effets laxatifs.Conserver à l'abris de la chaleur et de l'humidité.
Regulatory points
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Withdrawn from the market on 28 November 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Valeriana officinalis L.
Read the warning, when it applies and the studies cited
Valerian - VALERIANA OFFICINALIS
Route of administration: Oral
Cautions and warnings
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Mills et al. 2006; Blumenthal et al. 2003; Barnes et al. 2002).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Phillipson JD. Herbal Medicines: A guide for healthcare professionals. 2nd ed. London (UK): Pharmaceutical Press; 2002.
- Blumenthal M, Hall T, Goldberg A, Kunz T, Dinda K, Brinckmann J, Wollschlaeger B, editors. 2003. The ABC Clinical Guide to Herbs: Valerian. Austin, Texas: American Botanical Council.
- Mills E, Dugoua J, Perri D, Koren G. 2006. Herbal Medicines in Pregnancy and Lactation : An Evidence-Based Approach. London (GB): Taylor and Francis Medical.
When using this product avoid taking with alcohol or products that cause drowsiness (Brinker 2010; Gennaro et al. 2000).
Sources cited by Health Canada (2)
- Gennaro AR, Marderosian AHD, Hanson GR, Medwick T, editors. 2000. Remington: The Science and Practice of Pharmacy, 20th edition. Philadelphia (PA): Lippincott Williams & Wilkins.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications. 2010.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2016; ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (3)
- Bradley PR, editor. 1992. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (GB): British Herbal Medicine Association.
- EMA 2016. European Medicines Agency. Community Monograph on Valeriana Officinalis L., Radix. London (GB): EMEA Committee on Herbal Medicinal Products (HMPC), 02 Febuary 2016. [Accessed 2023 October 27]. Available from: https://www.ema.europa.eu/documents/herbal-monograph/final-european-union-herbal-monograph-valeriana-officinalis-l-radix_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Condition of application: Sleep aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists continuously for more than 4 weeks (chronic insomnia) (EMA 2016; Berardi et al. 2002; Dipiro et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. 2002. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association.
- Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. 2002. Pharmacotherapy: A Pathophysiologic Approach, 5th edition. New York (NY): The McGraw-Hill Companies, Inc.
- EMA 2016. European Medicines Agency. Community Monograph on Valeriana Officinalis L., Radix. London (GB): EMEA Committee on Herbal Medicinal Products (HMPC), 02 Febuary 2016. [Accessed 2023 October 27]. Available from: https://www.ema.europa.eu/documents/herbal-monograph/final-european-union-herbal-monograph-valeriana-officinalis-l-radix_en.pdf
Condition of application: Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : THALAMAG
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “THALAMAG Sérénité Jour et Nuit: composition and regulation”, https://compoatlas.com/en/supplements/products/284703-thalamag-serenite-jour-et-nuit, updated 15 November 2026.